Devices, systems and methods for reducing mitral regurgitation
The MLC device addresses the challenge of maintaining position and protecting cardiac tissues during transcatheter mitral regurgitation treatment by using a dual-tube design with a stopper and anchoring mechanism, achieving effective mitral regurgitation reduction and tissue protection.
Patent Information
- Application Number
- CN202080069844.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-10-03
- Filing Date
- 2020-10-02
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2040-10-02
AI Technical Summary
Existing transcatheter devices struggle to effectively reduce mitral regurgitation by maintaining the position of the mitral loop cerclage device in the coronary sinus and prevent it from being pushed back, while also protecting surrounding cardiac tissues from damage.
A mitral loop cerclage (MLC) device comprising a first and second protective tube with a cerclage rope, a handle, and an anchoring portion, designed to be inserted through the coronary sinus and tricuspid valve, with a stopper to maintain position and prevent entry into cardiac structures, and an anchoring mechanism to secure the device in place.
The MLC device effectively reduces mitral regurgitation by maintaining its position and protecting cardiac tissues, allowing for precise tension application to reduce mitral annular size and regurgitation through real-time imaging guidance.
Smart Images

Figure CN114514004B_ABST
Abstract
Description
Technical Field
[0001] The present disclosure relates to devices, systems and methods for reducing cardiac valve regurgitation, and more particularly to transcatheter devices, systems and methods for treating mitral valve regurgitation. Background Art
[0002] Mitral regurgitation is characterized by cardiomyopathy, mitral annular enlargement, and leaflet traction leading to poor constriction. The transcatheter mitral loop cerclage (MLC) device provides annular compression of the mitral annulus by forming a ring in the coronary sinus at the interventricular septum. The mitral loop cerclage device is required to maintain its position and not be pushed back into the coronary sinus. Summary of the invention
[0003] An MLC device for reducing mitral regurgitation comprises: a first protective tube and a second protective tube, the MLC device having a cerclage rope arranged inside the first protective tube and the second protective tube, the first protective tube and the second protective tube respectively having a proximal portion and a distal portion, the proximal portions of the first protective tube and the second protective tube are connected side by side along at least a portion of the length of the first protective tube and the second protective tube to define a handle, and the distal portions of the first protective tube and the second protective tube are subsequently separated to define a separation portion.
[0004] The MLC device has a stopper portion connected to a distal portion of the second protective tube and configured to prevent the second protective tube from further entering the myocardium, the cerclage rope has an arched portion disposed between the distal portions of the first protective tube and the second protective tube, the first protective tube has at least one anchoring portion disposed between the separation portion and the distal portion of the first protective tube, the anchoring portion being configured to be fixed into the coronary sinus and hold the tissue protection device in place.
[0005] The first protective tube is configured to be inserted through the coronary sinus to surround at least a portion of the mitral valve. The first protective tube has a preformed shape, and the first protective tube is configured to maintain the preformed shape when the first protective tube passes through the coronary sinus.
[0006] The second protective tube is configured to pass through the tricuspid valve and abut against the right ventricle side of the interventricular septum. The second protective tube has a prefabricated shape, and the second protective tube is configured to maintain the prefabricated shape when the second protective tube passes through the tricuspid valve. The second protective tube has sufficient rigidity to resist inward bending when a tensile force is applied.
[0007] A method for treating mitral regurgitation in a patient using an MLC device, comprising: (a) inserting a sheath catheter into a femoral vein; (b) inserting a guide catheter through the femoral sheath to engage the coronary sinus; (c) allowing a guide wire to penetrate the interventricular septum and exit and enter the right ventricle (RV) cavity; (d) placing a guide wire catcher in the right ventricle cavity through the femoral sheath and grabbing the exiting guide wire; (e) pulling the guide wire out to the femoral sheath with the guide wire catcher so that the guide wire forms a femoral vein path: inferior vena cava (IVC)-coronary sinus (CS)-right ventricle (RV) cavity-right atrium (RA)-inferior vena cava (IVC) C)-femoral vein; (f) connecting the proximal portion of the guide wire to the cerclage rope with a tension locking device; (g) replacing the guide wire with the cerclage rope by pulling the distal portion of the guide wire; (h) advancing the mitral ring cerclage device through the femoral sheath through the cerclage rope using a delivery system; (i) when the mitral ring cerclage device is at an optimal tension, fixing the anchor portion to keep the MLC device in place; (j) when the MLC device is in place, transmitting appropriate tension through the tension locking device under the guidance of real-time imaging such as echocardiography; and (k) cutting the cerclage rope with a cutting device. BRIEF DESCRIPTION OF THE DRAWINGS
[0008] Features and advantages of the present invention will be apparent from the following description and embodiments, which are described with reference to the following drawings.
[0009] Figure 1 An embodiment of a mitral ring cerclage device comprising a handle, a first tube, and a second tube is shown.
[0010] Figure 2 An embodiment of a mitral ring cerclage device is shown, showing a separation portion and a stop portion of a second arm portion.
[0011] Figure 3 An embodiment of a mitral ring cerclage device is shown, showing the lumen of the stop portion and the lumen of the first arm portion.
[0012] Figure 4 An embodiment of a cerclage cord is shown that includes an arched portion and an outer layer.
[0013] Figure 5 An embodiment of a cerclage cord is shown that includes an arched portion and an outer layer.
[0014] Figure 6An embodiment of a mitral valve ring cerclage device is shown as it is advanced through the cerclage tether.
[0015] Figure 7 An embodiment of a mitral valve ring cerclage device is shown as it is advanced through the cerclage tether.
[0016] Figure 8 An embodiment of a mitral valve ring cerclage device is shown as it is advanced through the cerclage tether.
[0017] Fig. 9 An embodiment of a mitral ring cerclage device is shown, showing how the mitral ring cerclage device is advanced over a cerclage tether.
[0018] Fig. 10A The following procedure is shown, whereby coronary venography performed with a balloon wedge catheter identifies the basilar septal perforator coronary vein through which the coronary vein guidewire is advanced.
[0019] Fig. 10B The following procedure is shown, positioning a target capture device into the right ventricular outflow tract to capture a guidewire passing from a coronary vein.
[0020] Fig. 10C The procedure for replacing a lead with a tension device with an integrated coronary protection element is shown.
[0021] Fig. 10D The process during the application of tension is shown, wherein the protective element prevents compression of the circumflex coronary artery by the snare.
[0022] Fig. 10E The following procedure is shown, in which the mitral ring cerclage device is shown as being in plane around the mitral valve annulus in a caudal left anterior oblique projection.
[0023] Fig.10F The following procedure is shown, wherein a tension lock device is inserted into the left clavicle pouch.
[0024] Fig.11 Shown is a tension lock device embedded in the left clavicle pouch.
[0025] Fig.12 An embodiment of a mitral ring cerclage device is shown when tension is relaxed.
[0026] Fig.13 An embodiment of a mitral ring cerclage device is shown with tension applied.
[0027] Fig.14 The placement of the stop on the IVS wall is shown.
[0028] Fig.15The first arm is shown encircling the mitral valve.
[0029] Fig.16 The anchor portion is shown placed on the first arm portion.
[0030] Fig.17 The anchor portion is shown placed on the first arm portion.
[0031] Fig.18 The anchor portion is shown placed on the first arm portion.
[0032] Fig.19 An embodiment of an anchoring portion is shown.
[0033] Fig. 20 The anchor is shown placed in the coronary sinus.
[0034] Fig.21 Preferred anchoring locations are shown.
[0035] Fig. 22 Preferred and other possible anchoring locations are shown. DETAILED DESCRIPTION
[0036] The same reference numerals in the accompanying drawings represent the same content. Certain terms used herein are for convenience only and should not be considered as limiting the present invention. The terms "distal portion" and "proximal portion" refer to "away from" and "close to" the doctor who inserts the introducer sheath into the patient's body, respectively. The terms include the words specifically mentioned, their derivatives and words of similar meaning.
[0037] like Figure 1 As shown, a mitral loop cerclage (MLC) device 10 may include a first tube 20 and a second tube 30. The first tube 20 may be configured to engage with the coronary sinus (CS). The second tube 30 may be configured to engage with the tricuspid valve (TV).
[0038] like Figure 2As shown, the first tube 20 includes a proximal portion 22, a distal portion 23, and a lumen 24 extending between the proximal portion 22 and the distal portion 23. The second tube 30 includes a proximal portion 32, a distal portion 33, and a lumen 34 extending between the proximal portion 32 and the distal portion 33. The proximal portions of the first tube 20 and the second tube 30 can be longitudinally connected side-by-side along at least a portion of the length of the first tube 20 and the second tube 30 to define a stem portion 14, and the distal portions of the first tube 20 and the second tube 30 can be subsequently separated to define a hinge portion 16. The first tube 20 and the second tube 30 can be made of a flexible material such as a synthetic material, rubber, soft plastic, or a metal material such as a coil spring.
[0039] Handle
[0040] like Figure 1 and Figure 2 As shown, the mitral ring cerclage device 10 may include a handle 14. The proximal end portions of the first tube 20 and the second tube 30 may be connected longitudinally side by side and then separated from each other at the distal end. The connection portion between the first tube 20 and the second tube 30 is defined as the handle 14. The portion where the first tube 20 and the second tube 30 begin to separate is defined as a separation portion 16. The length of the handle 14 may be varied as needed.
[0041] The handle 14 serves to stabilize the first tube 20 and the second tube 30 so as to maintain their positions. When the separation portion 16 is located on the orifice of the coronary sinus, the mitral ring cerclage device 10 is prevented from entering the coronary sinus or the tricuspid valve.
[0042] Separation Department
[0043] like Figure 1 and Figure 2 As shown, the mitral ring cerclage device 10 may include a separation portion 16. The separation portion 16 is defined as a portion where the first tube 20 and the second tube 30 begin to separate from each other. Fig.12 and Fig.13 As shown, the separation portion 16 may be placed at or near the ostium of the coronary sinus.
[0044] The function of the separation portion 16 is to stabilize the first tube 20 and the second tube 30 so as to maintain their positions. When the separation portion 16 is located on the coronary sinus ostium, the mitral ring cerclage device 10 is prevented from entering the coronary sinus or the tricuspid valve.
[0045] First arm for mitral valve
[0046] The first tube 20 may include a lumen 24 extending between a proximal portion 22 and a distal portion 23. Figure 2 As shown, the first arm portion 21 of the first tube 20 is defined as the portion from the separation portion 16 to the distal end portion 23. Figure 1 and Figure 2 As shown, the first arm portion 21 can be preformed with flexible materials such as synthetic materials, rubber, soft plastics, or metal materials such as coil springs, so that it can maintain the preformed shape when passing through the coronary sinus. Fig.12 and Fig.13 A first arm 21 is shown passing through the coronary sinus.
[0047] The first arm 21 is configured to be inserted through the coronary sinus to surround at least a portion of the mitral valve. Fig.13 As shown, the first arm portion 21 is configured to tighten the annulus of mitral valve to reduce regurgitation.
[0048] When the cerclage rope 50 is inserted into the mitral ring cerclage device 10, the first arm portion 21 prevents the cerclage rope 50 from directly contacting the coronary sinus and surrounding tissues from being damaged. The length of the first arm portion 21 can be varied according to different patients as needed. The length can be estimated and determined based on imaging of each patient in advance.
[0049] Second arm for tricuspid valve
[0050] The second tube 30 may include a lumen 34 extending between a proximal portion 32 and a distal portion 33. Figure 2 As shown, the second tube 30 includes a second arm portion 31 which is defined as a portion between the separation portion 16 and a distal end portion 33 of the second tube 30 .
[0051] The second arm 31 is configured to pass through the tricuspid valve. Figure 1 and Figure 2 As shown, the second arm portion 31 can be preformed with a flexible material such as a synthetic material, rubber, soft plastic, or a metal material such as a coil spring so that it can maintain the preformed shape when passing through the tricuspid valve. The second arm portion 31 can have sufficient rigidity to resist bending when the cerclage rope 54 is subjected to tension. Figure 12 to Figure 14 A second arm 31 passing through the tricuspid valve is shown. The length of the second arm 31 can vary according to the needs of the patient. The length can be estimated and determined based on prior imaging of each patient.
[0052] Stopper
[0053] The second tube 30 further includes a stopper 40. The stopper 40 may be attached to the distal end portion of the second tube 30. Figure 1 and Figure 2 As shown, the stopper 40 can be securely attached to the distal end portion 33 of the second tube 30. Figure 12 to Figure 14 As shown, the stopper 40 is configured to abut against the right ventricular side of the interventricular septum. The stopper 40 is configured to keep the second arm 31 in its preformed shape and position by abutting against the interventricular septum. When tension is applied to the cerclage rope 50, the stopper 40 also keeps the second arm 31 floating instead of in direct contact with the tricuspid valve. In addition, the stopper 40 prevents the distal end portion 33 of the second tube 30 from entering the interventricular septum.
[0054] like Figure 7 and Figure 8 As shown, the stopper 40 may include a lumen 41 in the middle thereof, where the cerclage string 50 may pass through the lumen. The size, shape and volume of the stopper 41 may vary according to the needs of the patient, but its diameter should be greater than the diameter of the second arm 31. Figure 7 In the figure, the shape of the stopper 40 is shown as a disc, but those skilled in the art should understand that the stopper 40 may also be in other shapes.
[0055] Tension cerclage rope
[0056] Figure 4 The cerclage cord 50 is shown. The cerclage cord 50 includes an arch portion 51. Figure 4 and Figure 5 As shown, the arched portion 51 is covered by an outer layer 52. The outer layer 52 is integrally applied to the arched portion 51.
[0057] Preferably, if Figure 8 As shown, the outer layer 52 may be coated longer and taper toward the stop 40. The arch 51 and its outer layer 52 are configured to protect the coronary artery and the surrounding cardiac tissue when tension is applied to the cerclage cord 50.
[0058] The cerclage cord 50 may be made of a synthetic material such as nylon, metal (ie, stainless steel), or nylon-coated metal. The outer layer 52 may be made of a biocompatible synthetic resin.
[0059] Anchorage
[0060] The preferred embodiment of the mitral ring cerclage device 10 may further include an anchoring portion 70. Fig.16 and Fig.17As shown, the anchoring portion 70 is preferably located near the first arm portion 21 of the separation portion 16. The anchoring portion 70 may also be disposed at other locations along the first arm portion 21.
[0061] Fig.21 and Fig. 22 A plurality of anchor locations are shown disposed along the first arm 21 and / or the second arm 31. Preferred anchor locations are marked as circles along the first arm 21 near the separation 16. Other possible anchor locations on the first arm 21 and the second arm 31 are marked as squares. When tension may be applied to the cerclage tether 50, the anchor 70 is configured to hold the mitral ring cerclage device 10 in place and prevent the mitral ring cerclage device 10 from further advancing into the coronary sinus.
[0062] like Figures 17 to 19 As shown, the anchoring portion 70 may include at least one anchoring head 71 and at least one anchoring arm 72. Fig.21 As shown, the anchor head 71 is configured to be fixed (stuck) in a preferred anchoring position. The anchor arm 72 is configured to be firmly attached to the first arm 21 and / or the second arm 31. A plurality of anchors 70 may be firmly attached to the first arm 21 and / or the second arm 31.
[0063] Mitral cerclage
[0064] Under moderate sedation (n=3) or general anesthesia (n=2), a 19-F×15 cm catheter sheath (Oscor, Palm Harbor, Florida) can be placed in the left subclavian vein (via a small pacemaker-like pocket) and the femoral vein. This allows the operator to stand in the right groin. Transesophageal echocardiography (TEE) or transthoracic echocardiography can be used under anesthesia or sedation, respectively, to interactively adjust the tension to reduce MR. Heparin can be administered to achieve an activated clotting time of >300 s.
[0065] A balloon-tip coronary sinus guiding catheter (Cello, Medtronic) can be placed from the left subclavian vein into the great cardiac vein, and a compression contrast venogram can be performed. Using coronary sinus guidance, a double-lumen 0.014-inch microcatheter (Crusade, Kaneka Medix, Osaka, Japan) can be placed into the basal septal perforator coronary vein over a 0.014-inch guidewire (Whisper, Abbott, Chicago, Illinois), which is then used to guide a stiff-tip 0.014-inch external guidewire (Astato XS 20, Asahi, Japan) through the ventricular septum into the RVOT. Fig. 10A Shown, coronary venography performed with a balloon wedge catheter identifies a basoseptal perforator coronary vein (arrow), through which a guidewire can be passed.
[0066] A transfemoral balloon wedge end hole catheter can be passed through the tricuspid orifice into the pulmonary artery and then used to exchange a mesh stent / snare combination in the right ventricular outflow tract (RVOT) as a target and capture system. Once in the RVOT, a crossing guidewire may be snagged and exposed through the femoral vein. Fig. 10B As shown, a target capture device can be positioned into the RVOT to snare a guidewire passed through a coronary vein.
[0067] The cerclage cord 50 can be attached to the guidewire using heat shrink tubing (polyether block amide, Cobalt Polymers, Cloverdale, California) and then pulled into position through the coronary sinus and ventricular septum. The distal portion of the guidewire can be transferred from the femoral to the subclavian sheath using an annular snare. Fig. 10C As shown, the guide wire may be replaced with a cerclage cord 50 including an integrated arch 51 (arrow).
[0068] Next, the mitral valve cerclage device 10 may be advanced through the two free ends 55 , 56 of the cerclage string 50 . Fig. 9The straightened first arm 21 and second arm 31 of the first tube 20 and second tube 30 housed in the sheath are shown. Once the cerclage string 50 is in place, the straightened first arm 21 and second arm 31 of the mitral ring cerclage device 10 are introduced from the distal end portion 23 of the first tube 20 and the distal end portion 33 of the second tube 30 through the two free ends 55 and 56 of the cerclage string 50. Once the mitral ring cerclage device 10 is in place in the heart, the first arm 21 and second arm 31 return to their preformed shapes, as shown in FIG. Fig.11 shown.
[0069] Diagnostic coronary angiography allows accurate positioning of the integrated arch 51 of the cerclage tether 50. Fig. 10D As shown, during application of tension, the arched portion 51 can prevent compression of the snare circumflex branch of the coronary artery.
[0070] During transthoracic echocardiography or TEE, tension can be applied interactively to achieve the desired reduction in mitral annular size and mitral regurgitation. Fig. 10E As shown, in the caudal left anterior oblique projection, the mitral ring cerclage device 10 is shown as being in a plane around the mitral valve annulus. Finally, the tension can be locked in the left subclavicular pocket and the skin incision closed. Fig.10F As shown, the tension lock 58 can be inserted into the left clavicle pouch.
[0071] MLC transfemoral surgery
[0072] In addition to the above-mentioned surgeries, transfemoral surgery for MLC may also be feasible. Transfemoral surgery may include the following steps: (1) inserting a sheath catheter into the femoral vein; (2) inserting a guide catheter through the femoral sheath to enter the coronary sinus; (3) passing a 0.014" guide wire through the interventricular septum and out and into the right ventricle (RV) cavity; (4) placing the guide wire catheter in the RV cavity through the femoral sheath and grabbing the outgoing guide wire; (5) using a catcher to pull the guide wire out of the femoral sheath so that the guide wire forms a femoral vein path: inferior vena cava (IVC)-coronary sinus (CS)-RV cavity-right atrium (RA)-IVC-femoral vein; (6) using a tension locking system 5 8. Connect the proximal portion of the guide wire to the cerclage rope 50; (7) replace the guide wire with the cerclage rope 50 by pulling the distal portion of the guide wire; (8) pass the mitral ring cerclage device 10 through the femoral sheath through the cerclage rope 50 using the delivery system; (9) when the mitral ring cerclage device 10 is at an optimal tension, fix the anchoring portion 70 to keep the MLC in place; (10) when the mitral ring cerclage device 10 is in place, under the guidance of real-time imaging (such as echocardiography), transmit appropriate tension through the tension locking device 58; (11) use a dedicated cutting device to cut the cerclage rope 50.
[0073] With reference to the embodiments and drawings described in detail above, the advantages and features of the present invention and methods for achieving them will become apparent. However, the present invention is not limited to the disclosed embodiments, and it can be implemented in various different forms. These embodiments are provided to enable the disclosure of the present invention and to fully inform the ordinary technicians in the field to which the present invention belongs. The present invention is limited only by the scope of the claims.
Claims
1. A mitral valve ring cerclage device for reducing mitral valve regurgitation, characterized in that: include: a first tube and a second tube, the first tube and the second tube having a proximal portion and a distal portion, respectively, the proximal portion of the first tube and the proximal portion of the second tube being connected side by side along at least a portion of the length of the first tube and the second tube to define a handle, and the distal portion of the first tube and the distal portion of the second tube being subsequently separated to define a separation portion; a cerclage rope, a portion of which is disposed inside the first tube and the second tube; as well as At least one anchoring portion, wherein the at least one anchoring portion is disposed at at least one position between the separation portion and the distal portion of the first tube, between the separation portion and the distal portion of the second tube, on the first tube near the separation portion, and on the second tube near the separation portion, wherein the at least one anchoring portion is configured to hold the mitral ring cerclage device in an appropriate position to prevent the mitral ring cerclage device from further entering the coronary sinus, wherein each anchoring portion includes at least one anchoring head and at least one anchoring arm, wherein the anchoring head is configured to be fixed to an anchoring position, and the anchoring arm is configured to be attached to the second tube.
2. The device according to claim 1, characterized in that At least one anchor can be secured to the coronary sinus.
3. The device according to claim 1, characterized in that At least one anchoring portion is disposed proximate to the separation portion.
4. The device according to claim 1, characterized in that At least one anchoring portion is disposed on the first tube proximate to the separation portion, and each anchoring portion includes at least one anchoring head and at least one anchoring arm, the anchoring arm being configured to be attached to the first tube, and the anchoring head being configured to be fixed to an anchoring position.
5. The device according to claim 1, characterized in that The mitral ring cerclage device has a stopper connected to the distal end portion of the second tube and configured to prevent the second tube from further entering the myocardium.
6. The device according to claim 1, characterized in that The cerclage cord has an arched portion disposed between distal ends of the first tube and the second tube.
7. The device according to claim 6, characterized in that The arched portion is coated with an outer layer, and the outer layer is coated to extend toward a distal end portion of the second tube and to be gradually tapered.
8. The device according to any one of claims 1 to 7, characterized in that The first tube is configured to be inserted through the coronary sinus to surround at least a portion of the mitral valve.
9. The device according to any one of claims 1 to 7, characterized in that The first tube has a preformed shape, and the first tube is configured to maintain the preformed shape when the first tube passes through the coronary sinus.
10. The device according to any one of claims 1 to 7, characterized in that The second tube is configured to pass through the tricuspid valve and abut against the right ventricular side of the ventricular septum.
11. The device according to any one of claims 1 to 7, characterized in that The second tube has a preformed shape, and the second tube is configured to maintain the preformed shape when the second tube passes through the tricuspid valve.
12. The device according to any one of claims 1 to 7, characterized in that The second tube is sufficiently rigid to resist inward bending when tension is applied thereto.
